290 related articles for article (PubMed ID: 37943548)
1. Hepatitis D: A Review.
Negro F; Lok AS
JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
[TBL] [Abstract][Full Text] [Related]
3. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
Ferrante ND; Lo Re V
Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis Delta Infection: A Clinical Review.
Pearlman B
Semin Liver Dis; 2023 Aug; 43(3):293-304. PubMed ID: 37473778
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
[TBL] [Abstract][Full Text] [Related]
7. [Role of the hepatitis Delta virus on the pathogenesis of hepatic cirrhosis and hepatocellular carcinoma. Recent advances].
Romeo R
Recenti Prog Med; 2010 Feb; 101(2):52-6. PubMed ID: 20433000
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of and New Therapies for Hepatitis D.
Koh C; Heller T; Glenn JS
Gastroenterology; 2019 Jan; 156(2):461-476.e1. PubMed ID: 30342879
[TBL] [Abstract][Full Text] [Related]
9. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of hepatitis D.
Farci P; Niro GA
Semin Liver Dis; 2012 Aug; 32(3):228-36. PubMed ID: 22932971
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatitis delta and HIV infection.
Soriano V; de Mendoza C; Treviño A; Ramos-Rincón JM; Moreno-Torres V; Corral O; Barreiro P
Liver Int; 2023 Aug; 43 Suppl 1():108-115. PubMed ID: 35748639
[TBL] [Abstract][Full Text] [Related]
12. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
[TBL] [Abstract][Full Text] [Related]
13. New therapies for hepatitis delta virus infection.
Loureiro D; Castelnau C; Tout I; Boyer N; Narguet S; Menasria Benazzouz S; Louis Z; Pons-Kerjean N; Giuly N; Marcellin P; Mansouri A; Asselah T
Liver Int; 2021 Jun; 41 Suppl 1():30-37. PubMed ID: 34155804
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir.
Brancaccio G; Fasano M; Grossi A; Santantonio TA; Gaeta GB
Aliment Pharmacol Ther; 2019 Apr; 49(8):1071-1076. PubMed ID: 30793345
[TBL] [Abstract][Full Text] [Related]
15. Management of chronic hepatitis B.
Wilt TJ; Shamliyan T; Shaukat A; Taylor BC; MacDonald R; Yuan JM; Johnson JR; Tacklind J; Rutks I; Kane RL
Evid Rep Technol Assess (Full Rep); 2008 Oct; (174):1-671. PubMed ID: 19408969
[TBL] [Abstract][Full Text] [Related]
16. HBV/HDV Coinfection: A Challenge for Therapeutics.
Koh C; Da BL; Glenn JS
Clin Liver Dis; 2019 Aug; 23(3):557-572. PubMed ID: 31266627
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation in delta virus infection.
Roche B; Samuel D
Semin Liver Dis; 2012 Aug; 32(3):245-55. PubMed ID: 22932973
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis delta: virological and clinical aspects.
Botelho-Souza LF; Vasconcelos MPA; Dos Santos AO; Salcedo JMV; Vieira DS
Virol J; 2017 Sep; 14(1):177. PubMed ID: 28903779
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic.
Sagnelli C; Pisaturo M; Curatolo C; Codella AV; Coppola N; Sagnelli E
World J Gastroenterol; 2021 Nov; 27(42):7271-7284. PubMed ID: 34876788
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of the Peginterferon treatment in chronic hepatitis HDV and compensate liver cirrhosis.
Tugui L; Dumitru M; Iacob S; Gheorghe L; Preda C; Dinu I; Becheanu G; Dumbrava M; Nicolae I; Andrei A; Lupu A; Diculescu M
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):368-75. PubMed ID: 25076702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
